We specialise in full-service custom research and consultancy for global healthcare. We use the full range of qualitative and quantitative techniques to undertake both ad hoc and tracking studies across a range of therapy areas and territories
Within prescription medicines, we have therapeutic specialists and experience in a broad range of therapy areas from chronic illnesses to rare diseases.
Consumer health and nutritionals
We combine our knowledge of the pharmaceutical sector with our understanding of patients and consumers to deliver integrated insights.
Medical devices and diagnostics
Our experience covers everything from insulin pens to large-scale surgical console systems. We use our knowledge of the unique market dynamics and regulatory nature of this sector to improve client understanding.
- Some example case studiesPatient Assistance Programme Evaluation for Cardiovascular Conditions
The challengeOur client had launched a self-injection treatment for cardiovascular conditions and were creating an accompanying Patient Assistance Programme (PAP) to educate patients in the use and uptake of this product. The client wanted to understand how successful the PAP was at meeting the needs of patients, trainers and prescribers, and whether it positively differentiated them from competitors. They wanted to evaluate each individual component…read more »Multiple Sclerosis new medical device research
The challengeOur client wanted to find out how best to develop an implantable delivery device with add-on services in the Multiple Sclerosis market. We were tasked with finding out whether such a device would be accepted by HCPs and patients. We also needed to identify the perceived benefit to stakeholders and offer ideas on how to optimize the device offering through the look of the…read more »Shifting perceptions of the use of probiotics in IBS Management
The challengeOur client was planning to launch an over-the-counter (OTC) probiotics product for the purposes of improving IBS management and wanted to understand current perceptions, practices and usage amoungst a range of healthcare professionals in emerging markets. They wanted to uncover potential leverage points to build a strong storyline and communication strategy for their product, which would encourage healthcare professionals to recommend its use to…read more »
- Our latest white papersUnderstanding the chronic disease patient journey in emerging markets
In this paper, we explore the chronic disease patient journey in emerging markets and provide you with the insights you require to identify the key inflection points in these rapidly changing and diverse regions.read more »US Presidential Election: The legacy of the Affordable Care Act and the future for healthcare
Our latest Free Thinking white paper explores the legacy of the Affordable Care Act and the future for healthcareread more »Are biosimilars the answer to the rising cost of RA treatment?
Our latest Free Thinking white paper explores why the uptake of Biosimilars has been slower than expected and asks what's next for RA?read more »